These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 12039105)
21. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels. Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899 [TBL] [Abstract][Full Text] [Related]
22. The effects on fetal development of high alpha-fetoprotein and maternal smoking. Heinonen S; Ryynänen M; Kirkinen P Am J Public Health; 1999 Apr; 89(4):561-3. PubMed ID: 10191802 [TBL] [Abstract][Full Text] [Related]
24. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Chandra S; Scott H; Dodds L; Watts C; Blight C; Van Den Hof M Am J Obstet Gynecol; 2003 Sep; 189(3):775-81. PubMed ID: 14526312 [TBL] [Abstract][Full Text] [Related]
25. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome. Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624 [TBL] [Abstract][Full Text] [Related]
26. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements. Simpson JL; Palomaki GE; Mercer B; Haddow JE; Andersen R; Sibai B; Elias S Am J Obstet Gynecol; 1995 Dec; 173(6):1742-8. PubMed ID: 8610755 [TBL] [Abstract][Full Text] [Related]
27. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation]. Hayashi M; Kohzu H Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554 [TBL] [Abstract][Full Text] [Related]
28. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein. Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411 [TBL] [Abstract][Full Text] [Related]
29. Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein levels. Puntachai P; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T Arch Gynecol Obstet; 2015 Jul; 292(1):81-5. PubMed ID: 25547063 [TBL] [Abstract][Full Text] [Related]
30. Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates. Spong CY; Sherer DM; Ghidini A; Jenkins CB; Seydel FD; Eglinton GS Obstet Gynecol; 1996 Jul; 88(1):24-8. PubMed ID: 8684756 [TBL] [Abstract][Full Text] [Related]
31. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol. Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420 [TBL] [Abstract][Full Text] [Related]
32. Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening. Killam WP; Miller RC; Seeds JW Obstet Gynecol; 1991 Aug; 78(2):257-61. PubMed ID: 1712441 [TBL] [Abstract][Full Text] [Related]
33. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels. Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514 [TBL] [Abstract][Full Text] [Related]
35. Maternal serum levels of alpha-fetoprotein and fetal fibronectin as markers of labor in the third trimester. Khandelwal M; Lynch L; Lockwood CJ; Ainbender E Am J Perinatol; 1995 May; 12(3):161-3. PubMed ID: 7541997 [TBL] [Abstract][Full Text] [Related]
36. Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies. Bernstein IM; Barth RA; Miller R; Capeless EL Obstet Gynecol; 1992 Jan; 79(1):71-4. PubMed ID: 1370124 [TBL] [Abstract][Full Text] [Related]
37. The significance of abnormally high and low maternal serum alpha-fetoprotein levels between 14 and 25 weeks of gestation. Ko TM; Hsieh FJ; Wu CC; Chang CH; Hsieh RF; Liu IJ; Hsieh CY; Lee TY J Formos Med Assoc; 1990 Jun; 89(6):456-60. PubMed ID: 1700059 [TBL] [Abstract][Full Text] [Related]
38. Prenatal diagnosis in diabetic gravidas: utility of ultrasound and maternal serum alpha-fetoprotein screening. Greene MF; Benacerraf BR Obstet Gynecol; 1991 Apr; 77(4):520-4. PubMed ID: 1706079 [TBL] [Abstract][Full Text] [Related]
39. The association between second-trimester maternal serum alpha-fetoprotein in 14-22 weeks and adverse pregnancy outcome. Dehghani-Firouzabadi R; Tayebi N; Ghasemi N; Tahmasbi Z Acta Med Iran; 2010; 48(4):234-8. PubMed ID: 21279936 [TBL] [Abstract][Full Text] [Related]
40. Maternal serum alpha fetoprotein among pregnant females in Alexandria. Baghagho EE; Kharboush IF; El-Kaffash DM; KarKour TA; Ismail SR; Mortada MM J Egypt Public Health Assoc; 2004; 79(1-2):59-81. PubMed ID: 16916050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]